OXFORD ASSET MANAGEMENT LLP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 160 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
OXFORD ASSET MANAGEMENT LLP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$742,000
-50.2%
54,859
-32.0%
0.02%
-48.4%
Q3 2018$1,489,000
+35.6%
80,625
+13.3%
0.03%
+34.8%
Q1 2018$1,098,000
+253.1%
71,158
+246.0%
0.02%
+228.6%
Q4 2017$311,000
-81.6%
20,566
-81.4%
0.01%
-88.3%
Q4 2016$1,686,000
-72.9%
110,276
-71.9%
0.06%
-68.8%
Q3 2016$6,225,000
+537.8%
391,981
+424.9%
0.19%
+500.0%
Q2 2016$976,000
-55.6%
74,681
-62.8%
0.03%
-49.2%
Q1 2016$2,197,000
-48.1%
200,782
-43.8%
0.06%
-37.0%
Q4 2015$4,235,000357,4950.10%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,855,515$43,661,00013.90%
BLUE JAY CAPITAL MANAGEMENT, LLC 772,369$11,810,0007.13%
Rubric Capital Management LP 1,275,000$19,495,0006.70%
SECTOR GAMMA AS 1,972,678$30,162,0005.68%
BRIDGER MANAGEMENT, LLC 1,879,313$28,735,0002.00%
Asymmetry Capital Management, L.P. 57,363$877,0001.63%
Orbimed Advisors 7,241,300$110,719,0001.41%
Broderick Brian C 144,476$2,209,0000.96%
Granahan Investment Management 1,408,000$21,528,0000.74%
Spark Investment Management LLC 499,200$7,632,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders